MML Investors Services
EW icon

MML Investors Services’s Edwards Lifesciences EW Stock Holding History

MML Investors Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Buy
57,760
+36,320
+169% +$3.04M 0.01% 967
2026
Q1 		$1.72M Buy
21,440
+3,658
+21% +$302K ﹤0.01% 1407
2025
Q4 		$1.52M Buy
17,782
+5,768
+48% +$473K ﹤0.01% 1536
2025
Q3 		$934K Buy
12,014
+4,355
+57% +$340K ﹤0.01% 1777
2025
Q2 		$599K Sell
7,659
-6,220
-45% -$464K ﹤0.01% 1975
2025
Q1 		$1.01M Buy
13,879
+742
+6% +$53.1K ﹤0.01% 1568
2024
Q4 		$973K Sell
13,137
-20,978
-61% -$1.47M ﹤0.01% 1524
2024
Q3 		$2.25M Sell
34,115
-64,525
-65% -$4.69M 0.01% 1031
2024
Q2 		$9.11M Sell
98,640
-9,449
-9% -$837K 0.04% 421
2024
Q1 		$10.3M Sell
108,089
-14,830
-12% -$1.25M 0.04% 400
2023
Q4 		$9.37M Buy
122,919
+27,488
+29% +$1.91M 0.04% 394
2023
Q3 		$6.61M Buy
95,431
+5,271
+6% +$424K 0.04% 441
2023
Q2 		$8.51M Buy
+90,160
New +$7.84M 0.05% 369
2023
Q1 		– Sell
-93,345
Closed -$6.96M – 2138
2022
Q4 		$6.96M Buy
93,345
+4,333
+5% +$334K 0.05% 391
2022
Q3 		$7.36M Buy
89,012
+82
+0.1% +$7.89K 0.06% 331
2022
Q2 		$8.46M Buy
88,930
+8,788
+11% +$910K 0.06% 293
2022
Q1 		$9.43M Buy
80,142
+5,264
+7% +$591K 0.07% 288
2021
Q4 		$9.7M Buy
74,878
+4,935
+7% +$576K 0.07% 284
2021
Q3 		$7.92M Buy
69,943
+5,663
+9% +$646K 0.06% 309
2021
Q2 		$6.66M Buy
64,280
+6,712
+12% +$633K 0.06% 330
2021
Q1 		$4.82M Buy
57,568
+10,775
+23% +$911K 0.05% 380
2020
Q4 		$4.27M Buy
46,793
+8,831
+23% +$733K 0.05% 352
2020
Q3 		$3.03M Buy
37,962
+6,705
+21% +$523K 0.04% 387
2020
Q2 		$2.16M Buy
31,257
+12,819
+70% +$911K 0.03% 474
2020
Q1 		$1.16M Buy
18,438
+1,863
+11% +$134K 0.02% 583
2019
Q4 		$1.29M Buy
16,575
+2,676
+19% +$209K 0.02% 624
2019
Q3 		$1.02M Sell
13,899
-1,338
-9% -$94K 0.02% 658
2019
Q2 		$938K Buy
15,237
+927
+6% +$56.1K 0.01% 741
2019
Q1 		$913K Sell
14,310
-936
-6% -$53.4K 0.01% 745
2018
Q4 		$778K Sell
15,246
-11,520
-43% -$583K 0.01% 715
2018
Q3 		$1.55M Buy
26,766
+3,036
+13% +$148K 0.03% 530
2018
Q2 		$1.15M Sell
23,730
-1,500
-6% -$70K 0.03% 519
2018
Q1 		$1.17M Sell
25,230
-1,803
-7% -$78.3K 0.02% 501
2017
Q4 		$1.02M Sell
27,033
-5,271
-16% -$193K 0.02% 544
2017
Q3 		$1.18M Buy
32,304
+3,837
+13% +$146K 0.02% 458
2017
Q2 		$1.12M Sell
28,467
-156
-0.5% -$5.69K 0.02% 471
2017
Q1 		$898K Buy
+28,623
New +$896K 0.02% 301

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

MML Investors Services's EW Position: Q2 2026 in Review

MML Investors Services increased its Edwards Lifesciences (EW) stake by 169% in Q2 2026, buying an estimated $3.04M and bringing the position to 57,760 shares worth $5.23M. The position accounts for 0.01% of the portfolio, ranked #967.

MML Investors Services first reported a position in EW in Q1 2017 and has held it in 37 quarters since. The position peaked at $10.3M in Q1 2024. 833 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MML Investors Services held 57,760 shares of Edwards Lifesciences worth $5.23M as of Q2 2026.
  • MML Investors Services bought 36,320 Edwards Lifesciences shares in Q2 2026, an estimated $3.04M.
  • Edwards Lifesciences made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #967 holding.
  • MML Investors Services first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 37 quarters since.
  • MML Investors Services's Edwards Lifesciences position peaked at $10.3M in Q1 2024.
  • 833 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.